We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ABPI Rebukes Four Drugmakers for Breaching Code of Practice
ABPI Rebukes Four Drugmakers for Breaching Code of Practice
The Association of the British Pharmaceutical Industry found four drugmakers — Celgene, Takeda, Vifor Pharma and Pierre Fabre — violated the group’s code of practice by engaging in activities ranging from inadequate quality management to deceptive drug promotion.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor